deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral Tablet
- RxCUI
- 2701438
- RxNorm name
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral Tablet
- Display name
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral Tablet
- Full name
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALYFTREK | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | Vertex Pharmaceuticals Incorporated | 7e635909-c6fd-4f0d-ae77-cdff03653a20 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 2701438 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7e635909-c6fd-4f0d-ae77-cdff03653a20 | deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [PSN] · deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [SCD] · deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 2024 | 20260323 |